Sanofi
SNY
756 hedge funds and large institutions have $16.3B invested in Sanofi in 2024 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 296 increasing their positions, 236 reducing their positions, and 60 closing their positions.
53% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 60
31% more call options, than puts
Call options by funds: $125M | Put options by funds: $95.4M
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
25% more repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 236
23% more capital invested
Capital invested by funds: $13.2B → $16.3B (+$3.01B)
4% more funds holding
Funds holding: 728 → 756 (+28)
0.74% more ownership
Funds ownership: 21.48% → 22.22% (+0.74%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$210M |
| 2 |
Morgan Stanley
New York
|
+$164M |
| 3 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$102M |
| 4 |
Jennison Associates
New York
|
+$92.9M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$76.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$356M |
| 2 |
AC
Armistice Capital
New York
|
-$49.7M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$47M |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$43.9M |
| 5 |
GAM
Groupama Asset Management
Paris,
France
|
-$40.4M |
SNY Hedge Fund Activity: Q3 2024 in Review
756 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2024, worth a combined $16.3B — up 23% from $13.2B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new SNY positions and 60 closed out — a net gain of 32 holders — while 296 added to existing stakes and 236 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $210M. The largest seller was Fidelity Investments, cutting an estimated $356M.
- 756 institutional investors held Sanofi (SNY) as of Q3 2024, up from 728 in Q2 2024.
- Funds reported $16.3B of Sanofi stock for Q3 2024, up 23% quarter-over-quarter.
- 92 funds opened new Sanofi positions in Q3 2024 and 60 closed out, a net change of +32 holders.
- The largest Sanofi buyer in Q3 2024 was T. Rowe Price Associates, an estimated $210M added.
- The largest Sanofi seller in Q3 2024 was Fidelity Investments, an estimated $356M sold.
Based on aggregated 13F filings for Q3 2024.